» Articles » PMID: 22904560

Dormant Origins, the Licensing Checkpoint, and the Response to Replicative Stresses

Overview
Date 2012 Aug 21
PMID 22904560
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

Only ∼10% of replication origins that are licensed by loading minichromosome maintenance 2-7 (MCM2-7) complexes are normally used, with the majority remaining dormant. If replication fork progression is inhibited, nearby dormant origins initiate to ensure that all of the chromosomal DNA is replicated. At the same time, DNA damage-response kinases are activated, which preferentially suppress the assembly of new replication factories. This diverts initiation events away from completely new areas of the genome toward regions experiencing replicative stress. Mice hypomorphic for MCM2-7, which activate fewer dormant origins in response to replication inhibition, are cancer-prone and are genetically unstable. The licensing checkpoint delays entry into S phase if an insufficient number of origins have been licensed. In contrast, humans with Meier-Gorlin syndrome have mutations in pre-RC proteins and show defects in cell proliferation that may be a consequence of chronic activation of the licensing checkpoint.

Citing Articles

Reconstitution of human DNA licensing and the structural and functional analysis of key intermediates.

Wells J, Edwardes L, Leber V, Allyjaun S, Peach M, Tomkins J Nat Commun. 2025; 16(1):478.

PMID: 39779677 PMC: 11711466. DOI: 10.1038/s41467-024-55772-z.


Combination of AID2 and BromoTag expands the utility of degron-based protein knockdowns.

Hatoyama Y, Islam M, Bond A, Hayashi K, Ciulli A, Kanemaki M EMBO Rep. 2024; 25(9):4062-4077.

PMID: 39179892 PMC: 11387839. DOI: 10.1038/s44319-024-00224-4.


The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial.

Giudice E, Huang T, Nair J, Zurcher G, McCoy A, Nousome D Nat Commun. 2024; 15(1):2805.

PMID: 38555285 PMC: 10981752. DOI: 10.1038/s41467-024-47215-6.


DNA hypomethylation activates Cdk4/6 and Atr to induce DNA replication and cell cycle arrest to constrain liver outgrowth in zebrafish.

Madakashira B, Magnani E, Ranjan S, Sadler K Nucleic Acids Res. 2024; 52(6):3069-3087.

PMID: 38321933 PMC: 11014291. DOI: 10.1093/nar/gkae031.


Depletion of Labile Iron Induces Replication Stress and Enhances Responses to Chemoradiation in Non-Small-Cell Lung Cancer.

Bayanbold K, Singhania M, Fath M, Searby C, Stolwijk J, Henrich J Antioxidants (Basel). 2023; 12(11).

PMID: 38001858 PMC: 10669787. DOI: 10.3390/antiox12112005.


References
1.
Lambert S, Carr A . Checkpoint responses to replication fork barriers. Biochimie. 2005; 87(7):591-602. DOI: 10.1016/j.biochi.2004.10.020. View

2.
Francis D, Davies N, Bryant J, Hughes S, Sibson D, Fitchett P . Effects of psoralen on replicon size and mean rate of DNA synthesis in partially synchronized cells of Pisum sativum L. Exp Cell Res. 1985; 158(2):500-8. DOI: 10.1016/0014-4827(85)90473-2. View

3.
Tada S, Li A, Maiorano D, Mechali M, J Blow J . Repression of origin assembly in metaphase depends on inhibition of RLF-B/Cdt1 by geminin. Nat Cell Biol. 2001; 3(2):107-13. PMC: 3605706. DOI: 10.1038/35055000. View

4.
Zachos G, Rainey M, Gillespie D . Chk1-deficient tumour cells are viable but exhibit multiple checkpoint and survival defects. EMBO J. 2003; 22(3):713-23. PMC: 140744. DOI: 10.1093/emboj/cdg060. View

5.
Leonhardt H, Rahn H, Weinzierl P, Sporbert A, Cremer T, Zink D . Dynamics of DNA replication factories in living cells. J Cell Biol. 2000; 149(2):271-80. PMC: 2175147. DOI: 10.1083/jcb.149.2.271. View